Actualités Bioporto A/s - 0JJM | Actions London Stock Exchange

BioPorto commences process to appoint new Chair of the Board of Directors

BioPorto commences process to appoint new Chair of the Board of Directors December 16, 2024 Announcement no. 23 BioPorto commences process to...

BioPorto Announces Interim Results and Business Update for the Third Quarter and Nine Months of Fiscal 2024

BioPorto Announces Interim Results and Business Update for the Third Quarter and Nine Months of Fiscal 2024 November 14, 2024Announcement no. 22...

Notice convening the Annual General Meeting in BioPorto A/S

Notice convening the Annual General Meeting in BioPorto A/S April 4, 2024Announcement no. 6 Notice convening the Annual General Meeting in...

BioPorto implements changes to the Executive Management.

BioPorto implements changes to the Executive Management. January 9, 2024 Announcement no. 01 BioPorto implements changes to the Executive...

Managers’ transactions

Managers’ transactions June 28, 2023Announcement no. 13 Managers’ transactions In connection with the completion of BioPorto A/S’ rights...

BioPorto A/S announces completion of rights issue; total number of shares and voting rights

BioPorto A/S announces completion of rights issue; total number of shares and voting rights June 23, 2023Announcement no. 12 BioPorto A/S...

BioPorto A/S announces results of rights issue

BioPorto A/S announces results of rights issue June 21, 2023Announcement no. 11 BioPorto A/S announces results of rights issue COPENHAGEN...

BioPorto A/S initiates a rights issue with pre-emptive rights for its existing shareholders and proceeds of up to approximately DKK 59.4 million with approximately DKK 16.6 million pre-subscribed pursuant to advance commitments

BioPorto A/S initiates a rights issue with pre-emptive rights for its existing shareholders and proceeds of up to approximately DKK 59.4...

Notice convening the Annual General Meeting in BioPorto A/S

Notice convening the Annual General Meeting in BioPorto A/S April 5, 2023Announcement no. 5 Notice convening the Annual General Meeting in...

NOTICE CONVENING THE EXTRAORDINARY GENERAL MEETING

NOTICE CONVENING THE EXTRAORDINARY GENERAL MEETING November 1, 2022 Announcement no. 14 NOTICE CONVENING THE EXTRAORDINARY GENERAL MEETING...

Strong Performance of The NGAL Test Drives Revenue Growth

Strong Performance of The NGAL Test Drives Revenue Growth May 11, 2022Announcement no. 11 Strong Performance of The NGAL Test Drives Revenue...

Grant of warrants

Grant of warrants May 5, 2022Announcement no. 10 Grant of warrants The Board of Directors of BioPorto A/S (“BioPorto”) (Nasdaq: BIOPOR), in...

BioPorto A/S - Annual General Meeting

BioPorto A/S - Annual General Meeting April 28, 2022Announcement no. 9 BioPorto A/S - Annual General Meeting Today, BioPorto A/S held its...

Notice Convening the Annual General Meeting

Notice Convening the Annual General Meeting April 6, 2022 Announcement no. 8 NOTICE CONVENING THE ANNUAL GENERAL MEETING The Board...

BioPorto Publishes 2021 Annual Report

BioPorto Publishes 2021 Annual Report April 6, 2022Announcement no. 7 BioPorto Publishes 2021 Annual Report BioPorto A/S (BioPorto), an in...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Bioporto A/s (0JJM)

Outils de qualité professionnelle, pour des investisseurs individuels.

0JJM Actualités

BioPorto commences process to appoint new Chair of the Board of Directors

BioPorto Announces Interim Results and Business Update for the Third Quarter and Nine Months of Fiscal 2024

Notice convening the Annual General Meeting in BioPorto A/S

BioPorto implements changes to the Executive Management.

Managers’ transactions

BioPorto A/S announces completion of rights issue; total number of shares and voting rights

BioPorto A/S announces results of rights issue

BioPorto A/S initiates a rights issue with pre-emptive rights for its existing shareholders and proceeds of up to approximately DKK 59.4 million with approximately DKK 16.6 million pre-subscribed pursuant to advance commitments

Notice convening the Annual General Meeting in BioPorto A/S

NOTICE CONVENING THE EXTRAORDINARY GENERAL MEETING

Strong Performance of The NGAL Test Drives Revenue Growth

Grant of warrants

BioPorto A/S - Annual General Meeting

Notice Convening the Annual General Meeting

BioPorto Publishes 2021 Annual Report

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Bioporto A/s (0JJM) Actualités

Bioporto A/s (0JJM)

Outils de qualité professionnelle, pour des investisseurs individuels.

0JJM Actualités

BioPorto commences process to appoint new Chair of the Board of Directors

BioPorto Announces Interim Results and Business Update for the Third Quarter and Nine Months of Fiscal 2024

Notice convening the Annual General Meeting in BioPorto A/S

BioPorto implements changes to the Executive Management.

Managers’ transactions

BioPorto A/S announces completion of rights issue; total number of shares and voting rights

BioPorto A/S announces results of rights issue

BioPorto A/S initiates a rights issue with pre-emptive rights for its existing shareholders and proceeds of up to approximately DKK 59.4 million with approximately DKK 16.6 million pre-subscribed pursuant to advance commitments

Notice convening the Annual General Meeting in BioPorto A/S

NOTICE CONVENING THE EXTRAORDINARY GENERAL MEETING

Strong Performance of The NGAL Test Drives Revenue Growth

Grant of warrants

BioPorto A/S - Annual General Meeting

Notice Convening the Annual General Meeting

BioPorto Publishes 2021 Annual Report

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application